I-Mab Announces First Patient Dosed in Phase 1 Clinical Trial of Claudin 18.2 and 4-1BB ...

Retrieved on: 2022-07-23 04:12:24

Tags for this article:

Click the tags to see associated articles and topics

I-Mab Announces First Patient Dosed in Phase 1 Clinical Trial of Claudin 18.2 and 4-1BB .... View article details on hiswai:

Excerpt

GAITHERSBURG, MD, USA and SHANGHAI, China I July 22, 2022 I I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company ...

Article found on: pipelinereview.com